ask="N/A"
ask_size="N/A"
average_daily_volume="10997"
bid="4.3100"
bid_size="200"
book_value="-2.0510"
change="+0.1025"
change_from_200_day_moving_average="0.0102"
change_from_50_day_moving_average="0.0697"
change_from_52_week_high="-1.1175"
change_From_52_week_low="0.5525"
change_in_percent="+2.3402%"
close="4.4825"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.8770"
ebitda="-3.99M"
eps_estimate_current_year="-2.9500"
eps_estimate_next_quarter="-0.1300"
eps_estimate_next_year="-0.4800"
ex_dividend_date="N/A"
float_shares="2882000"
high="4.4825"
high_52_weeks="5.6000"
last_trade_date="2/1/2017"
last_trade_price="4.4825"
last_trade_size="126"
last_trade_time="12:02pm"
low="4.4825"
low_52_weeks="3.9300"
market_capitalization="43.17M"
moving_average_200_day="4.4723"
moving_average_50_day="4.4128"
name="AzurRx BioPharma
Inc."
notes="N/A"
one_year_target_price="7.0000"
open="4.3500"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+0.2274%"
percent_change_from_50_day_moving_average="+1.5804%"
percent_change_from_52_week_high="-19.9554%"
percent_change_from_52_week_low="+14.0585%"
previous_close="4.3800"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="9631000"
short_ratio="0.5300"
stock_exchange="NCM"
symbol="AZRX"
volume="138"
weeks_range_52="3.9300 - 5.6000"
